Advertisement

Klinische Wochenschrift

, Volume 68, Issue 2, pp 142–145 | Cite as

Influence of B vitamins on binding properties of serotonin receptors in the CNS of rats

  • K. Dakshinamurti
  • S. K. Sharma
  • D. Bonke
Kurzmitteilung

Summary

Treatment of normal adult rats with pyridoxine or a B-vitamin mixture resembling Neurobion® 1 led to an increase in serotonin content of various brain areas and to a decrease in the number of serotonin S2 receptors. The results indicate that the pyridoxal phosphate level in regions of the brain regulates the extent of decarboxylation of 5-hydroxytryptophan, the precursor of serotonin. The results also suggest a continuum from deficiency in pyridoxine to treatment of animals with a moderate excess of pyridoxine which is reflected in the synthesis and secretion into the synaptic cleft of the neurotransmitter serotonin.

Key words

Pyridoxine B Vitamins CNS Serotonin receptor binding Rat 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bartoszyk GD, Wild A (1989) B-Vitamins potentiate the anti-nociceptive effects of diclofenac in carrageenin-induced hyperalgesia in the rat tail pressure test. Neurosci Lett 101:95–100Google Scholar
  2. 2.
    Dakshinamurti K, Leblancq WD, Herchl R, Havlicek V (1976) Nonparallel changes in brain monamines of pyridoxine-deficient growing rats. Exp Brain Res 26:255–366Google Scholar
  3. 3.
    Dakshinamurti K, Paulose CS, Thliveris JA, Vriend J (1985) Thyroid function in pyridoxine-deficient young rats. J Endocrinol 104:339–344Google Scholar
  4. 4.
    Dakshinamurti K (1982) Neurobiology of pyridoxine. In: Draper HH (ed) Advances in nutritional research, vol 4. Plenum Press, New York, pp 143–179Google Scholar
  5. 5.
    Dakshinamurti K, Paulose CS, Vriend J (1986) Hypothyroidism of hypothalamic origin in pyridoxine-deficient rats. J Endocrinol 109:345–349Google Scholar
  6. 6.
    Dakshinamurti K, Paulose CS, Viswanathan M, Siow YL (1988) Neuroendocrinology of pyridoxine deficiency. Neurosci Biobehav Rev 12:189–193Google Scholar
  7. 7.
    Glowinski J, Iversen LI (1966) Regional studies of catecholamines in the rat brain. The disposition of (3H)norepinephrin, (3H)dopamine and (3H)-DOPA in various regions of the brain. J Neurochem 13:655–669Google Scholar
  8. 8.
    Jurna I, Bonke D (1988) Depression of nociceptive activity evoked in the rat thalamus by vitamin B-complex and vitamin B6. Soc Neurosci Abstr 14:324 (Abstract 134.8)Google Scholar
  9. 9.
    Kilpatrick IC, Jones MW, Phillipson OT (1986) A semiautomatic analysis method for catecholamines, indolamines and semiprominent metabolites in microdissected regions of the nervous system: an isocratic HPLC technique employing caulometric detection and minimal sample preparation. J Neurochem 46:1865–1876Google Scholar
  10. 10.
    Leysen JE, Niemegeers CJE, Van Nueten JM, Laduron PM (1982) (3H)-Ketanserin (R1468), a selective3H-ligand for serotonin2 receptor binding sites. Mol Pharmacol 21:301–314Google Scholar
  11. 11.
    Murphy RM, Zelman FP (1987) Differential effects of substance-P on serotonin-modulated spinal nociceptive reflexes. Psychopharmacology 93:118–121Google Scholar
  12. 12.
    Paulose CS, Dakshinamurti K (1985) Effect of pyridoxine deficiency on young rats on high affinity serotonin and dopamine receptor. J Neurosci Res 12:263–270Google Scholar
  13. 13.
    Scatchard T (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672Google Scholar
  14. 14.
    Siow YL, Dakshinamurti K (1985) Effect of pyridoxine deficiency on aromatic L-amino acid decarboxylase in adult rat brain. Exp Brain Res 59:575–581Google Scholar
  15. 15.
    Viswanathan M, Siow YL, Paulose CS, Dakshinamurti K (1988) Pineal indolamine metabolism in pyridoxine-deficient rat. Brain Res 473:37–42Google Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • K. Dakshinamurti
    • 1
  • S. K. Sharma
    • 1
  • D. Bonke
    • 2
  1. 1.Department of Biochemistry and Molecular Biology, Faculty of MedicineUniversity of ManitobaWinnipegCanada
  2. 2.E. Merck, Clinical Drug DevelopmentDarmstadt

Personalised recommendations